Concepedia

Publication | Open Access

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

35

Citations

23

References

2016

Year

Abstract

Intratumoural and peritumoural DT01 in combination with radiotherapy is safe and pharmacokinetic analyses suggest a systemic passage of DT01.

References

YearCitations

Page 1